Prime Success Sends Letter to Sinovac Biotech Shareholders

  • HONG KONG--(BUSINESS WIRE)--Prime Success L.P., (together with its affiliates, “Prime Success” or “we”), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”) with ownership of approximately 8% of the Company's outstanding shares, today issued a letter to shareholders in connection with the upcoming Special Meeting of Shareholders (the “Special Meeting”) scheduled for July 8, 2025. The full text of the letter can be viewed here and by visiting www.SaveSino.